GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study Links Visceral Fat to Inflammation and Cardiovascular Risk in Prediabetes

by GOAI
Share To

A recent study has identified significant links between visceral fat, inflammation, and cardiovascular risk in individuals with prediabetes. Researchers examined the role of visceral adipose tissue—fat stored around internal organs—and its connection to key biomarkers associated with inflammation and heart health. The findings highlight the potential impact of visceral fat on cardiovascular risks in people at an early stage of metabolic dysfunction.

The investigation focused on how specific mediators, including high-density lipoprotein (HDL), interact with visceral fat to influence inflammatory responses and cardiovascular health. The study provides detailed insights into the biological mechanisms that may contribute to increased heart disease risk in individuals with prediabetes. Researchers emphasized the importance of understanding these relationships to better address the complex interplay between obesity, diabetes, and cardiovascular conditions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top